MotherToBaby is currently enrolling people in an observational study to learn about Benlysta® (belimumab) during pregnancy. All studies are conducted through phone interviews—no changes to your current medications or travel are required. Learn more ➡️ https://t.co/9czpuSLD8c
For #WorldLupusDay, we’re making lupus visible and sharing what the MotherToBaby Lupus Fact Sheet says about pregnancy, risks, and why research matters.
Swipe through — then visit our Lupus Hub to learn more: https://t.co/HZcAjwbjGO
Where will the wind take us? To a future where every mom and baby is protected.
Have you seen us yet? Snap a pic and tag us!
Be part of research that helps protect babies and improves guidance for parents. Learn more at https://t.co/rRcjs8ApEf
Finders Keepers! Who knows this spot? 👀
Tag us when you find our MotherToBaby Pregnancy Studies goody bag!
Be part of research that helps protect babies and improves guidance for parents. Learn more at https://t.co/rRcjs8ApEf
-
#TDAP#MotherToBabyPregnancyStudies#billboard
We’re taking over the city to spread the word about the MotherToBaby Tdap Vaccine in Pregnancy Study.
Have you seen us yet? Snap a pic and tag us!
Be part of research that helps protect babies and improves guidance for parents. Learn more at https://t.co/rRcjs8ApEf
-
#TDAP
MotherToBaby is enrolling pregnant people in an observational study on KESIMPTA® use for multiple sclerosis. Conducted via phone interviews; participants may receive up to $250 for completing activities. No treatment changes or travel required. Learn more: https://t.co/vc28xMNdY7
Seeking influencers to empower maternal voices.
We are looking for content creators to post about their
personal experiences managing health conditions during
Pregnancy.
Inspire other moms today.
https://t.co/ejeEod3jtb
We’re hiring 💜 MotherToBaby Pregnancy Studies seeks a full-time, on-site Clinical Research Assistant/Interviewer (French-speaking). Conduct interviews in English & French with pregnant participants. Apply: https://t.co/MtESxl27ok
#NowHiring
New research published by MotherToBaby Pregnancy Studies in the 𝑨𝒎𝒆𝒓𝒊𝒄𝒂𝒏 𝑱𝒐𝒖𝒓𝒏𝒂𝒍 𝒐𝒇 𝑮𝒂𝒔𝒕𝒓𝒐𝒆𝒏𝒕𝒆𝒓𝒐𝒍𝒐𝒈𝒚 found no increased risk of adverse pregnancy outcomes with vedolizumab (Entyvio®) exposure during pregnancy.
Learn more: https://t.co/nFuU7I7WaK
MotherToBaby is currently enrolling pregnant women in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
As we reflect on 2025, we’re proud of the progress made at MotherToBaby Pregnancy Studies, and we are grateful to the healthcare providers, community partners, and participants who made it possible.
We look forward to continuing it together in the year ahead.
This year, MotherToBaby Pregnancy Studies connected with communities, providers, and partners across the country. All in service shaping the future of Healthy Pregnancy, Together.
MotherToBaby is currently enrolling pregnant people in observational studies looking at Tremfya® (guselkumab) and Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
MotherToBaby is currently enrolling pregnant women in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c